Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Cognex Launches New Version of Identification and Label Verification Software

Published: Monday, April 15, 2013
Last Updated: Monday, April 15, 2013
Bookmark and Share
In-Sight Track & Trace enables pharmaceutical serialization.

Cognex Corporation  announced a new version of the In-Sight® Track & Trace identification and data verification solution for healthcare serialization.

A follow up to successful deployments of In-Sight Track & Trace 1.0, this version includes enhancements that address additional requirements for pharmaceutical and medical device manufacturers to achieve unit-level product traceability.

Customers can use In-Sight Track & Trace 2.0 with multiple networked In-Sight vision systems to decode human-readable text along with 2-D and 1-D barcodes, including Data Matrix, GS1-128, GS1 DataBar, securPharm and Pharmacode.

“In-Sight Track & Trace is an off-the-shelf label verification and serialization software supplement for our pharmaceutical customers required to comply with GS1 and FDA regulations and similar laws worldwide,” says Herbert Lade, Vice President and Business Unit Manager, Vision Systems. He adds, “In the newest version, we incorporated bundling reading support, secondary authentication capability and our OCRMax™ tool for the highest read rates in the industry. This new feature provides superior read rates of human-readable dates, lot codes and serial numbers.”

The pre-programmed add-on software package needs little set up through a touch screen or HMI. In-Sight Track & Trace can be easily integrated into third-party serialization software or MES with industrial protocol support and built-in I/O controls. The technical controls needed for FDA 21 CFR Part 11 validation, including secure user authentication and automatic audit trail generation, are also included.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos